Athersys Inc

Business Services · Ohio, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

3201 Carnegie Ave, Cleveland, Ohio, 4411...

Phone Number

(216) 431-9900

Revenue

$6 Million

Stock Symbol

ATHX

Industry

Business Services Research & Development

About Athersys Inc

Athersys is a biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the neurological, inflammatory and immune, cardiovascular and other critical care indications and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization.Explore more
Athersys Inc's Social MediaSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: ATHXShow more

Athersys Inc Org Chart

PhoneEmail
BD
United States flag for contact location.

Project Management Director, Regulatory

PhoneEmail
SC
United States flag for contact location.

Senior Director, Process Development, Regener...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
LB
United States flag for contact location.

Senior Manager, Quality

PhoneEmail
AT
United States flag for contact location.

Senior Manager, Operations

PhoneEmail
AR
United States flag for contact location.

Manager, Process Development

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Athersys Inc

Compare insights from companies similar to Athersys Inc, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Athersys Inc

$6M
11-50
Public
$264.5M
1995
BD
Brooke DapolitoProject Management Director, Regulatory
$13.1M
51-200
Public
$60.9M
1990
$8.7M
51-200
Private
$62.6M
1997
<$5M
11-50
Private
-
2005
JS
John SalvadorChief Operating Officer
<$5M
11-50
Public
$46.8M
2014
11-50
Public
$55.9M
2000
Alla Patlis, Interim Chief Financial Officer at Brainstorm Cell Therapeutics
Alla PatlisInterim Chief Financial Officer
Illustration of an envelope

Athersys Inc Tech Stack

A closer look at the technologies used by Athersys Inc

Top Business Services Companies

Frequently Asked Questions Regarding Athersys Inc

What is Athersys Inc's stock symbol?
Athersys Inc's stock symbol is ATHX
What is Athersys Inc's official website?
Athersys Inc's official website is www.athersys.com
What is Athersys Inc's Revenue?
Athersys Inc's revenue is $6 Million
What is Athersys Inc's SIC code?
Athersys Inc's SIC: 87,873
What is Athersys Inc's NAICS code?
Athersys Inc's NAICS: 54,541
How many employees does Athersys Inc have?
Athersys Inc has 11-50 employees
What industry does Athersys Inc belong to?
Athersys Inc is in the industry of: Business Services, Research & Development
What is Athersys Inc competition?
Athersys Inc top competitors include: Lineage Cell Therapeutics, Brainstorm Cell Therapeutics, Cytori Therapeutics, Minerva Biotechnologies
What companies has Athersys Inc acquired?
Athersys Inc has acquired the companies: Athersys Inc
What technology does Athersys Inc use?
Some of the popular technologies that Athersys Inc uses are: Q4, DocuSign, WordPress.org, PHP
How do I contact Athersys Inc?
Athersys Inc contact info: Phone number: (216) 431-9900 Website: www.athersys.com
What does Athersys Inc do?

Athersys is a biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the neurological, in... flammatory and immune, cardiovascular and other critical care indications and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization.Read More

What are Athersys Inc social media links?
Athersys Inc Linkedin page Athersys Inc Twitter page
Who invested in Athersys Inc?
Athersys Inc has 15 investors including Pappas Ventures, Hambrecht & Quist Capital Management, RA Capital Management and Accipiter Capital Management.
Is Athersys Inc a public company?
Yes, Athersys Inc is a public company and is traded under the symbol ATHX
See more information about Athersys Inc

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.